Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules
Open Access
- 1 February 2002
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 128 (1) , 47-57
Abstract
We investigated which vaccination schedule gives best protection to the vaccinating population, in case there is a measles epidemic in an area with low vaccine coverage. We considered combinations of an early measles vaccination (none, at 6 months or at 9 months), a measles–mumps–rubella (MMR) vaccination around the first birthday (at either 11 or 14 months), and MMR vaccination at an older age (at either 4 or 9 years). The different estimates on measures of protection (percentage of susceptibles, number of reported cases in an epidemic year, percentage of lifetime spent susceptible) relied on a mathematical model of decline of maternal antibody levels with age, and the impact of that antibody level on seroconversion and immunity. Model parameters were estimated from a Dutch population-based serological survey on measles antibodies. Different measures of protection favoured different vaccination schedules, but dropping the age of second MMR vaccination prevents considerably more cases than an extra early measles vaccination or dropping the age of first MMR vaccination.Keywords
This publication has 29 references indexed in Scilit:
- Mumps and Rubella Eliminated From FinlandJAMA, 2000
- Health Consequences of Religious and Philosophical Exemptions From Immunization LawsJAMA, 1999
- Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injectionVaccine, 1995
- Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adultsVaccine, 1994
- Duration of the immune response to MMR vaccine in children of two age-different groupsEuropean Journal of Epidemiology, 1993
- Impact of Haemophilus influenzae Type b Polysaccharide-Tetanus Protein Conjugate Vaccine on Responses to Concurrently Administered Diphtheria-Tetanus-Pertussis VaccineJAMA, 1992
- Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose scheduleVaccine, 1991
- Methods for screening the naturally acquired and vaccine-induced immunity to the measles virusBiologicals, 1990
- Optimal ages of vaccination for measlesMathematical Biosciences, 1988
- Evaluation of age-specific vaccination strategiesTheoretical Population Biology, 1984